Try it
Pharmacology · Chemotherapy: irinotecan and UGT1A1
Sample itemA man with metastatic colorectal cancer develops grade 4 neutropenia and severe delayed diarrhoea after his first dose of irinotecan. Genotyping shows a homozygous reduced-function allele of the enzyme that inactivates its active metabolite SN-38. Which enzyme is it?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. UDP-glucuronosyltransferase 1A1
Irinotecan is converted by carboxylesterase to SN-38, the active topoisomerase I inhibitor, which UGT1A1 glucuronidates for elimination. The UGT1A1*28 variant reduces this step, so SN-38 accumulates and neutropenia and diarrhoea worsen.
Option by option
A. Cytochrome P450 2D6
CYP2D6 activates tamoxifen and codeine and does not handle SN-38.
B. Dihydropyrimidine dehydrogenase
Dihydropyrimidine dehydrogenase breaks down fluorouracil and capecitabine.
C. UDP-glucuronosyltransferase 1A1 (correct)
Correct. UGT1A1 glucuronidates SN-38, and reduced activity increases toxicity.
D. Thiopurine methyltransferase
Thiopurine methyltransferase inactivates mercaptopurine and azathioprine.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?